Profile: Protox Therapeutics Inc. specializes in using genetic engineering to transform naturally occurring proteins into novel targeted therapeutics for the treatment of prostate diseases and various cancers. We offer a pipeline of clinical stage product candidates derived from the Porxin™ and Inxin™ technology platforms. Our PRX302 drug is used for the treatment of benign prostatic hyperplasia and localized prostate cancer. Our PRX321 drug is used for primary brain cancer.